Remedy Entertainment has reported a profitable start to 2026, marking a pivotal period of transition for the Finnish developer.

Under the leadership of new CEO Jean-Charles Gaudechon, the studio is leaning into its “Remedy Connected Universe” strategy, leveraging a mix of steady back-catalogue sales and high-profile upcoming releases to navigate a volatile global gaming market.

The first quarter saw Remedy achieve an operating profit of EUR 1.0 million on revenues of EUR 13.1 million. Profits were bolstered by a significant increase in game sales and royalties, compensating for a decrease in development fees.

Control Resonant

The studio’s financial stability is currently anchored by the continued success of its core franchises. Alan Wake 2 continued to earn royalties throughout the quarter, further boosted by a new platform deal with Amazon Luna. Meanwhile, the original Control has officially surpassed 6 million lifetime copies sold. Remedy views the original title as a strategic entry point for new players, with sales currently outpacing the same period last year as anticipation builds for the sequel.

The primary focus for the studio is the upcoming launch of Control Resonant. Now in full production, the title is being positioned as a “must-have day-one purchase.” Remedy has significantly scaled its marketing efforts, including recent gameplay debuts at PlayStation’s State of Play and technical showcases with partner NVIDIA. As the most localized Remedy game to date (supporting eight audio languages including Chinese and Brazilian Portugues) it represents the studio’s most ambitious global push.

In parallel, the highly anticipated Max Payne 1&2 remake, in partnership with Rockstar Games, has officially entered full production. This project remains a cornerstone of Remedy’s development roadmap, alongside the continued maintenance of FBC: Firebreak, which moved to maintenance mode in March to allow the studio to shift resources toward its future slate.

Control Resonant

However, perhaps most intriguing for fans is the confirmation of a “New Project” currently in the proof-of-concept stage. While details remain under wraps, this unannounced title is being developed under Remedy’s self-publishing model, where the studio retains full ownership of the IP. This stage focuses on testing core gameplay mechanics and creative pillars before committing to full-scale production, signaling that Remedy is already planning the next evolution of its “Connected Universe.”

It’s an exciting time for Remedy and its fans. The studio is transitioning from a “cult favorite” to a self-publishing powerhouse while keeping that weird, wonderful DNA intact, which is no small feat.

The “New Project” in proof-of-concept is definitely the one to watch. Remedy is usually very deliberate with their world-building, so whatever is brewing there likely has deep ties to the lore we already know.

CEO Jean-Charles Gaudechon emphasized that the studio is “right-sized” for its current ambitions, with a focus on commercial discipline and creative identity. The outlook for the remainder of 2026 remains positive, with Remedy expecting both full-year revenue and EBITDA to increase.

As the studio approaches the launch of Control Resonant, it remains committed to its 2030 vision: doubling its 2024 revenue and establishing itself as a premier global creative powerhouse.